Osteoporosis and Alzheimer's disease (AD) are both degenerative diseases. Osteoporosis
often proceeds cognitive deficits, and multiple studies have revealed common triggers that …

A significant clinical association between osteoporosis (OP) and fibromyalgia (FM) has been
shown in the literature. Given the need for specific biomarkers to improve OP and FM …

Objectives The hypoxia-inducible factor 1-α (HIF1α), a key molecule in mediating bone-
vessel crosstalk, has been considered a promising target for treating osteoporosis caused …

Background Bone remodeling is a complex process, and many conditions (including drug
exposure) lead to osteoporosis. Here, we sought to detect new disproportionality signals for …

Background Clinical studies indicated that postmenopausal osteoporosis (PMOP) often
accompanied by iron overload risk factor, which exacerbated bone metabolism disorders …

Background Bushenhuoxue (BSHX) formula, a ten-compound herbal decoction, is widely
used to treat postmenopausal osteoporosis (PMOP) in China. However, the mechanism is …

Objective Postmenopausal osteoporosis (PMOP) is a common systemic metabolic bone
disorder that is owing to the reduced estrogen secretion and imbalance of bone absorption …

Primary osteoporosis (POP) is a widespread and severe disorder of bone metabolism
characterized by reduced bone mass and destruction of bone structure, frequently inducing …

Multiple sclerosis is a chronic disease of the central nervous system characterized by
demyelination and destruction of axons. The most common form of the disease is the …

Osteoporosis (OP) is a chronic systemic bone metabolism disease characterized by
decreased bone mass, microarchitectural deterioration, and fragility fractures. With the …